Clinical trials
Active, not recruiting Phase 3 Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gan & Lee Pharmaceuticals. | 3 |
| Eli Lilly and Company | 1 |
| Garvan Institute of Medical Research | 1 |
| Hospital Clinic of Barcelona | 1 |
| Kailera | 1 |
| Mt. Sinai Medical Center, Miami | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Pfizer | 1 |
| University College, London | 1 |
| University of Sydney | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 12 |
| Insulin Resistance | 4 |
| Obesity | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Endocrine System Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Metabolic Diseases | 2 |
| Overweight | 2 |
| Body Weight | 1 |
| Cerebrovascular Disorders | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.